Targeted Drug HER2 Inhibitors for NSCLC Market Key Drivers and Forecast 2025-2032
Targeted Drug HER2 Inhibitors for NSCLC Market Trends And Drivers The global targeted drug HER2 inhibitors for non-small cell lung cancer (NSCLC) market was valued at approximately USD 2.5 billion in 2022. It is projected to grow significantly, reaching an estimated USD 7.3 billion by 2030. The market is expected to expand at a compound […]
Continue Reading